Issue 1, 2020

Less may be more: an informed reflection on molecular descriptors for drug design and discovery

Abstract

The phenomenal advances of machine learning in the context of drug design and discovery have led to the development of a plethora of molecular descriptors. In fact, many of these “standard” descriptors are now readily available via open source, easy-to-use computational tools. As a result, it is not uncommon to take advantage of large numbers – up to thousands in some cases – of these descriptors to predict the functional properties of drug-like molecules. This “strength in numbers” approach does usually provide excellent flexibility – and thus, good numerical accuracy – to the machine learning framework of choice; however, it suffers from a lack of transparency, in that it becomes very challenging to pinpoint the – usually, few – descriptors that are playing a key role in determining the functional properties of a given molecule. In this work, we show that just a handful of well-tailored molecular descriptors may often be capable to predict the functional properties of drug-like molecules with an accuracy comparable to that obtained by using hundreds of standard descriptors. In particular, we apply feature selection and genetic algorithms to in-house descriptors we have developed building on junction trees and symmetry functions, respectively. We find that information from as few as 10–20 molecular fragments is often enough to predict with decent accuracy even complex biomedical activities. In addition, we demonstrate that the usage of small sets of optimised symmetry functions may pave the way towards the prediction of the physical properties of drugs in their solid phases – a pivotal challenge for the pharmaceutical industry. Thus, this work brings strong arguments in support of the usage of small numbers of selected descriptors to discover the structure–function relation of drug-like molecules – as opposed to blindly leveraging the flexibility of the thousands of molecular descriptors currently available.

Graphical abstract: Less may be more: an informed reflection on molecular descriptors for drug design and discovery

Supplementary files

Article information

Article type
Paper
Submitted
19 اگست 2019
Accepted
07 نومبر 2019
First published
08 نومبر 2019

Mol. Syst. Des. Eng., 2020,5, 317-329

Less may be more: an informed reflection on molecular descriptors for drug design and discovery

T. Barnard, H. Hagan, S. Tseng and G. C. Sosso, Mol. Syst. Des. Eng., 2020, 5, 317 DOI: 10.1039/C9ME00109C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements